View in EDS

Pretreatment with alendronate augments lipid A-induced IFN-β production via upregulation of cGAS expression.

Saved in:

Bibliographic Details
Title:	Pretreatment with alendronate augments lipid A-induced IFN-β production via upregulation of cGAS expression.
Authors:	Watanabe S; Department of Infectious Diseases, Ohu University Graduate School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima, 963-8041, Japan., Kiyoura Y; Department of Infectious Diseases, Ohu University Graduate School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima, 963-8041, Japan.; Department of Oral Medical Sciences, Ohu University School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima, 963-8041, Japan., Tamai R; Department of Infectious Diseases, Ohu University Graduate School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima, 963-8041, Japan. r-tamai@den.ohu-u.ac.jp.; Department of Oral Medical Sciences, Ohu University School of Dentistry, 31-1 Misumido, Tomitamachi, Koriyama, Fukushima, 963-8041, Japan. r-tamai@den.ohu-u.ac.jp.
Source:	Pharmacological reports : PR [Pharmacol Rep] 2025 Oct; Vol. 77 (5), pp. 1389-1399. Date of Electronic Publication: 2025 Aug 14.
Publication Type:	Journal Article
Journal Info:	Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2299-5684 (Electronic) Linking ISSN: 17341140 NLM ISO Abbreviation: Pharmacol Rep Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2299-5684
DOI:	10.1007/s43440-025-00773-y